Papers associated with nav1

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

referenced by:

	Action of clathrodin and analogues on voltage-gated sodium channels., Peigneur S, Zula A, Zidar N, Chan-Porter F, Kirby R, Madge D, Ilaš J, Kikelj D, Tytgat J., Mar Drugs. March 28, 2014; 12 (4): 2132-43.
	Asymmetric functional contributions of acidic and aromatic side chains in sodium channel voltage-sensor domains., Pless SA, Elstone FD, Niciforovic AP, Galpin JD, Yang R, Kurata HT, Ahern CA., J Gen Physiol. May 1, 2014; 143 (5): 645-56.
	Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels., Klint JK, Berecki G, Durek T, Mobli M, Knapp O, King GF, Adams DJ, Alewood PF, Rash LD., Biochem Pharmacol. May 15, 2014; 89 (2): 276-86.
	Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents., Gilchrist J, Dutton S, Diaz-Bustamante M, McPherson A, Olivares N, Kalia J, Escayg A, Bosmans F., ACS Chem Biol. May 16, 2014; 9 (5): 1204-12.
	Metergoline inhibits the neuronal Nav1.2 voltage-dependent Na(+) channels expressed in Xenopus oocytes., Lee JH, Liu J, Shin M, Hong M, Nah SY, Bae H., Acta Pharmacol Sin. July 1, 2014; 35 (7): 862-8.
	Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder., Friedrich C, Rinné S, Zumhagen S, Kiper AK, Silbernagel N, Netter MF, Stallmeyer B, Schulze-Bahr E, Decher N., EMBO Mol Med. July 1, 2014; 6 (7): 937-51.
	Voltage-dependent blockade by bupivacaine of cardiac sodium channels expressed in Xenopus oocytes., Zhang H, Ji H, Liu Z, Ji Y, You X, Ding G, Cheng Z., Neurosci Bull. August 1, 2014; 30 (4): 697-710.
	Disrupted coupling of gating charge displacement to Na+ current activation for DIIS4 mutations in hypokalemic periodic paralysis., Mi W, Rybalchenko V, Cannon SC., J Gen Physiol. August 1, 2014; 144 (2): 137-45.
	Neurosteroids allopregnanolone sulfate and pregnanolone sulfate have diverse effect on the α subunit of the neuronal voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 expressed in xenopus oocytes., Horishita T, Yanagihara N, Ueno S, Sudo Y, Uezono Y, Okura D, Minami T, Kawasaki T, Sata T., Anesthesiology. September 1, 2014; 121 (3): 620-31.
	Characterization of the honeybee AmNaV1 channel and tools to assess the toxicity of insecticides., Gosselin-Badaroudine P, Moreau A, Delemotte L, Cens T, Collet C, Rousset M, Charnet P, Klein ML, Chahine M., Sci Rep. January 12, 2015; 5 12475.
	Xenopus borealis as an alternative source of oocytes for biophysical and pharmacological studies of neuronal ion channels., Cristofori-Armstrong B, Soh MS, Talwar S, Brown DL, Griffin JD, Dekan Z, Stow JL, King GF, Lynch JW, Rash LD., Sci Rep. January 12, 2015; 5 14763.
	Α- and β-subunit composition of voltage-gated sodium channels investigated with μ-conotoxins and the recently discovered μO§-conotoxin GVIIJ., Wilson MJ, Zhang MM, Gajewiak J, Azam L, Rivier JE, Olivera BM, Yoshikami D., J Neurophysiol. April 1, 2015; 113 (7): 2289-301.
	Spatiotemporal integration of developmental cues in neural development., Borodinsky LN, Belgacem YH, Swapna I, Visina O, Balashova OA, Sequerra EB, Tu MK, Levin JB, Spencer KA, Castro PA, Hamilton AM, Shim S., Dev Neurobiol. April 1, 2015; 75 (4): 349-59.
	The Scorpion Toxin Tf2 from Tityus fasciolatus Promotes Nav1.3 Opening., Camargos TS, Bosmans F, Rego SC, Mourão CB, Schwartz EF., PLoS One. June 5, 2015; 10 (6): e0128578.
	Probing the Redox States of Sodium Channel Cysteines at the Binding Site of μO§-Conotoxin GVIIJ., Zhang MM, Gajewiak J, Azam L, Bulaj G, Olivera BM, Yoshikami D., Biochemistry. June 30, 2015; 54 (25): 3911-20.
	Revealing the Function and the Structural Model of Ts4: Insights into the "Non-Toxic" Toxin from Tityus serrulatus Venom., Pucca MB, Cerni FA, Peigneur S, Bordon KC, Tytgat J, Arantes EC., Toxins (Basel). June 30, 2015; 7 (7): 2534-50.
	Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula., Chow CY, Cristofori-Armstrong B, Undheim EA, King GF, Rash LD., Toxins (Basel). June 30, 2015; 7 (7): 2494-513.
	A gamut of undiscovered electrophysiological effects produced by Tityus serrulatus toxin 1 on NaV-type isoforms., Peigneur S, Cologna CT, Cremonez CM, Mille BG, Pucca MB, Cuypers E, Arantes EC, Tytgat J., Neuropharmacology. August 1, 2015; 95 269-77.
	Bioelectric memory: modeling resting potential bistability in amphibian embryos and mammalian cells., Law R, Levin M., Plant Physiol. October 15, 2015; 12 22.
	Heterologous expression of NaV1.9 chimeras in various cell systems., Goral RO, Leipold E, Nematian-Ardestani E, Heinemann SH., Pflugers Arch. December 1, 2015; 467 (12): 2423-35.
	Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7., Klint JK, Chin YK, Mobli M., Mol Pharmacol. December 1, 2015; 88 (6): 1002-10.
	Binary architecture of the Nav1.2-β2 signaling complex., Das S, Gilchrist J, Bosmans F, Van Petegem F., Elife. January 28, 2016; 5
	Differential effects of the recombinant toxin PnTx4(5-5) from the spider Phoneutria nigriventer on mammalian and insect sodium channels., Paiva AL, Matavel A, Peigneur S, Cordeiro MN, Tytgat J, Diniz MR, de Lima ME., Biochimie. February 1, 2016; 121 326-35.
	Retigabine holds KV7 channels open and stabilizes the resting potential., Corbin-Leftwich A, Mossadeq SM, Ha J, Ruchala I, Le AH, Villalba-Galea CA., J Gen Physiol. March 1, 2016; 147 (3): 229-41.
	Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy., Zaharieva IT, Thor MG, Oates EC, van Karnebeek C, Hendson G, Blom E, Witting N, Rasmussen M, Gabbett MT, Ravenscroft G, Sframeli M, Suetterlin K, Sarkozy A, D'Argenzio L, Hartley L, Matthews E, Pitt M, Vissing J, Ballegaard M, Krarup C, Slørdahl A, Halvorsen H, Ye XC, Zhang LH, Løkken N, Werlauff U, Abdelsayed M, Davis MR, Feng L, Phadke R, Sewry CA, Morgan JE, Laing NG, Vallance H, Ruben P, Hanna MG, Lewis S, Kamsteeg EJ, Männikkö R, Muntoni F., Brain. March 1, 2016; 139 (Pt 3): 674-91.
	Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy., Freyermuth F, Rau F, Kokunai Y, Linke T, Sellier C, Nakamori M, Kino Y, Arandel L, Jollet A, Thibault C, Philipps M, Vicaire S, Jost B, Udd B, Day JW, Duboc D, Wahbi K, Matsumura T, Fujimura H, Mochizuki H, Deryckere F, Kimura T, Nukina N, Ishiura S, Lacroix V, Campan-Fournier A, Navratil V, Chautard E, Auboeuf D, Horie M, Imoto K, Lee KY, Swanson MS, de Munain AL, Inada S, Itoh H, Nakazawa K, Ashihara T, Wang E, Zimmer T, Furling D, Takahashi MP, Charlet-Berguerand N., Nat Commun. April 11, 2016; 7 11067.
	Ultrasound modulates ion channel currents., Kubanek J, Shi J, Marsh J, Chen D, Deng C, Cui J., Sci Rep. April 26, 2016; 6 24170.
	Fast-onset lidocaine block of rat NaV1.4 channels suggests involvement of a second high-affinity open state., Gingrich KJ, Wagner LE., Biochim Biophys Acta. June 1, 2016; 1858 (6): 1175-88.
	Mutant SOD1 protein increases Nav1.3 channel excitability., Kubat Öktem E, Mruk K, Chang J, Akin A, Kobertz WR, Brown RH., J Biol Phys. June 1, 2016; 42 (3): 351-70.
	Electrophysiological characterization of a large set of novel variants in the SCN5A-gene: identification of novel LQTS3 and BrS mutations., Ortiz-Bonnin B, Rinné S, Moss R, Streit AK, Scharf M, Richter K, Stöber A, Pfeufer A, Seemann G, Kääb S, Beckmann BM, Decher N., Pflugers Arch. August 1, 2016; 468 (8): 1375-87.
	Amyloid precursor protein modulates Nav1.6 sodium channel currents through a Go-coupled JNK pathway., Li S, Wang X, Ma QH, Yang WL, Zhang XG, Dawe GS, Xiao ZC., Sci Rep. December 23, 2016; 6 39320.
	Mefloquine inhibits voltage dependent Nav1.4 channel by overlapping the local anaesthetic binding site., Paiz-Candia B, Islas AA, Sánchez-Solano A, Mancilla-Simbro C, Scior T, Millan-PerezPeña L, Salinas-Stefanon EM., Eur J Pharmacol. February 5, 2017; 796 215-223.
	Regulation of Na+ channel inactivation by the DIII and DIV voltage-sensing domains., Hsu EJ, Zhu W, Schubert AR, Voelker T, Varga Z, Silva JR., J Gen Physiol. March 6, 2017; 149 (3): 389-403.
	Mapping of voltage sensor positions in resting and inactivated mammalian sodium channels by LRET., Kubota T, Durek T, Dang B, Finol-Urdaneta RK, Craik DJ, Kent SB, French RJ, Bezanilla F, Correa AM., Proc Natl Acad Sci U S A. March 7, 2017; 114 (10): E1857-E1865.
	Functional reconstitution of rat Nav1.6 sodium channels in vitro for studies of pyrethroid action., Soderlund DM, Tan J, He B., Neurotoxicology. May 1, 2017; 60 142-149.
	Pharmacology of the Nav1.1 domain IV voltage sensor reveals coupling between inactivation gating processes., Osteen JD, Sampson K, Iyer V, Julius D, Bosmans F., Proc Natl Acad Sci U S A. June 27, 2017; 114 (26): 6836-6841.
	Biophysical characterization of the Varroa destructor NaV1 sodium channel and its affinity for τ-fluvalinate insecticide., Gosselin-Badaroudine P, Chahine M., FASEB J. July 1, 2017; 31 (7): 3066-3071.
	Depolarization of the conductance-voltage relationship in the NaV1.5 mutant, E1784K, is due to altered fast inactivation., Peters CH, Yu A, Zhu W, Silva JR, Ruben PC., PLoS One. September 8, 2017; 12 (9): e0184605.
	Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes., Horishita T, Yanagihara N, Ueno S, Okura D, Horishita R, Minami T, Ogata Y, Sudo Y, Uezono Y, Sata T, Kawasaki T., Naunyn Schmiedebergs Arch Pharmacol. December 1, 2017; 390 (12): 1255-1270.
	Improving the characterization of calcium channel gating pore currents with Stac3., Chahine M., J Gen Physiol. March 5, 2018; 150 (3): 375-378.
	Spider toxin inhibits gating pore currents underlying periodic paralysis., Männikkö R, Shenkarev ZO, Thor MG, Berkut AA, Myshkin MY, Paramonov AS, Kulbatskii DS, Kuzmin DA, Sampedro Castañeda M, King L, Wilson ER, Lyukmanova EN, Kirpichnikov MP, Schorge S, Bosmans F, Hanna MG, Kullmann DM, Vassilevski AA., Proc Natl Acad Sci U S A. April 24, 2018; 115 (17): 4495-4500.
	The neurosteroid allopregnanolone sulfate inhibits Nav1.3 α subunit-containing voltage-gated sodium channels, expressed in Xenopus oocytes., Horishita T, Yanagihara N, Ueno S, Okura D, Horishita R, Minami T, Ogata Y, Sudo Y, Uezono Y, Kawasaki T., J Pharmacol Sci. May 1, 2018; 137 (1): 93-97.
	BK channel inhibition by strong extracellular acidification., Zhou Y, Xia XM, Lingle CJ., Elife. July 2, 2018; 7
	Phoneutria nigriventer Spider Toxin PnTx2-1 (δ-Ctenitoxin-Pn1a) Is a Modulator of Sodium Channel Gating., Peigneur S, Paiva ALB, Cordeiro MN, Borges MH, Diniz MRV, de Lima ME, Tytgat J., Toxins (Basel). August 21, 2018; 10 (9):
	Anesthetic-sensitive ion channel modulation is associated with a molar water solubility cut-off., Brosnan RJ, Pham TL., BMC Pharmacol Toxicol. September 14, 2018; 19 (1): 57.
	A Xenopus oocyte model system to study action potentials., Corbin-Leftwich A, Small HE, Robinson HH, Villalba-Galea CA, Boland LM., J Gen Physiol. November 5, 2018; 150 (11): 1583-1593.
	Loss-of-function of Nav1.8/D1639N linked to human pain can be rescued by lidocaine., Kaluza L, Meents JE, Hampl M, Rösseler C, Hautvast PAI, Detro-Dassen S, Hausmann R, Schmalzing G, Lampert A., Pflugers Arch. December 1, 2018; 470 (12): 1787-1801.
	Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives., Pugsley MK, Yong SL, Goldin AL, Hayes ES, Walker MJA., Eur J Pharmacol. February 5, 2019; 844 241-252.
	Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation., Zhu W, Mazzanti A, Voelker TL, Hou P, Moreno JD, Angsutararux P, Naegle KM, Priori SG, Silva JR., Circ Res. February 15, 2019; 124 (4): 539-552.
	Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors., Peigneur S, Cheneval O, Maiti M, Leipold E, Heinemann SH, Lescrinier E, Herdewijn P, De Lima ME, Craik DJ, Schroeder CI, Tytgat J., FASEB J. March 1, 2019; 33 (3): 3693-3703.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 ???pagination.result.next???